Pro Medicus Limited (ASX:PME) Announces Full-Year Results
Financial Performance
Pro Medicus Limited reported full-year revenue from ordinary activities of $213.0 million, a 31.9% increase. Net profit reached $115.2 million, up 39.2% compared to the previous year. The company’s cash and other financial assets stood at $210.7 million, rising 35.5%, while remaining debt-free.
Operational Achievements
Pro Medicus achieved a record year with $520 million in new contracts, including a $330 million ten-year agreement with Trinity Health and other significant contracts in North America and Australia. Additionally, the company secured $130 million in contract renewals and sold additional modules to existing clients such as NYU Langone and Duke Health.
Dividend Declaration
The company declared a fully-franked final dividend of 30 cents per share.
Executive Comments
Dr Sam Hupert, CEO of Pro Medicus, stated, “All key financial metrics headed in the right direction, and we continued our trajectory of strong, profitable growth. The majority of the contracts we signed were in the second half of the year and will come on stream this coming year and beyond, so there is a very sizeable revenue pathway in front of us.”
Motley Fool contributor Kiarra Jackson has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
This article was generated using GPT-4o mini, a Large Language Model (LLM), to generate summaries of investing news. While AI is generating the content, we know better than to blindly trust our future robot overlords, and every article is edited and fact-checked by an editor holding the appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content of everything published by The Capital Club.
